BenQ Medical Technology expects its revenue and profit to remain on a growth track in the second half of 2022, buoyed by stable global demand for healthcare equipment.
To cash in on the brisk demand, the company will adopt a three-pronged strategy to boost sales and sustain long-term growth, according to company vice chairman HP Yang.
According to Yang, the three-pronged strategy is: optimizing its business portfolios, expanding its medical care services, and venturing into the smart medical care business
As with its business portfolios, the company expects demand for medical equipment and materials from Europe, Southeast Asia, and South America to stage a strong rebound in the rest of the year, Yang said.
The company is expanding its medical care services as it is optimistic about the development trend of long-term care services. Therefore, BenQ Medical will commit more investments in pharmacies and smart medicines.
For smart medical care, the company will continue to develop related solutions and applications for telemedicine needs and deepen its deployment in digital dentistry.
For the second quarter of 2022, the company posted revenue of NT$802 million (US$26.47 million), up 30% sequentially and 138% annually. Net profit for the quarter reached NT$34.9 million, up 938% on year.
Revenue for the first half of 2022 totaled NT$1.417 billion, increasing 112% from a year earlier, and net profit reached NT$123 million.
Sales of medical consumables alone grew 40% on year in the first half of 2022, with related revenue accounting for over 20% of its total sales in the year.